Piramal Pharma
Piramal Pharma Ltd is an Indian pharmaceutical company providing contract development, manufacturing, and consumer healthcare products. The company manufactures active pharmaceutical ingredients, complex hospital generics, over-the-counter medicines, and specialized drug formulations. Main revenue drivers include contract development and manufacturing organization services alongside branded consumer healthcare product sales. Piramal Pharma serves global pharmaceutical enterprises, hospital purchasing networks, and consumer retail healthcare buyers across North America, Europe, and India. The company holds a prominent position in complex hospital generics, inhaled anesthetics, and global pharmaceutical CDMO services. Headquartered in Mumbai, India, Piramal Pharma Ltd is listed on the National Stock Exchange of India and the BSE.
4 of the funds FundTelligence covers report a position in Piramal Pharma.
- Legal name
- Piramal Pharma Ltd
- Sector
- Health Care
- Country
- India
- Funds holding it
- 4
Funds holding Piramal Pharma
- Storebrand Emerging Markets Plus — Storebrand · 0.02 % (full portfolio disclosed, October 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)
- Storebrand Indeks Nye Markeder — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Global All Countries — Storebrand · 0.0 % (full portfolio disclosed, October 2026)